Lexology October 7, 2019
Baker McKenzie

The healthcare and life sciences sector is being reshaped by technology in so many ways. Wearables, apps, software and artificial intelligence offer big solutions for pharma, medtech and healthcare service providers in relation to the remote monitoring of users and patients. It has also led to new players in telemedicine, online pharmacies and other forms of digital delivery of healthcare. Technology will be a driver for future M&A activity amid challenging global economic headwinds, and both healthcare and technology companies are seeking their slice of the pie in a global industry worth USD 7.2 trillion a year (source: World Health Organization, 2015).

Some of the key trends that we are expecting to grow include:

  • M&A activity in healthcare is...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Apps, Biotechnology, Digital Health, Precision Medicine, Provider, Technology, Wearables
A Better Connected Care Journey
‘Think about the hype’ - AI holds disruptive potential for health care
Venture-backed telemental health care companies are creating a new opioid epidemic
Will Synthetic, AI-Based Digital Humans Change Pharma and Life Sciences? Q&A with Abid Rahman, SVP Innovation, EVERSANA
Investigators Train AI Systems to Predict RA Outcomes

Share This Article